CY1122935T1 - Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο - Google Patents

Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο

Info

Publication number
CY1122935T1
CY1122935T1 CY20201100399T CY201100399T CY1122935T1 CY 1122935 T1 CY1122935 T1 CY 1122935T1 CY 20201100399 T CY20201100399 T CY 20201100399T CY 201100399 T CY201100399 T CY 201100399T CY 1122935 T1 CY1122935 T1 CY 1122935T1
Authority
CY
Cyprus
Prior art keywords
glycogen
water solubility
based water
solubility enhancer
complexes
Prior art date
Application number
CY20201100399T
Other languages
English (en)
Inventor
Vincenzo Russo
Elisa Liberati
Serena Tongiani
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of CY1122935T1 publication Critical patent/CY1122935T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε πολυμερή που βασίζονται στο γλυκογόνο και στη χρήση αυτών για την ενίσχυση της διαλυτότητας στο νερό λιπόφιλων ενώσεων, σε σύμπλοκα των εν λόγω βασιζόμενων στο γλυκογόνο πολυμερών και στη χρήση αυτών για χορήγηση λιπόφιλων ενώσεων, και σε φαρμακευτικές, διατροφοφαρμακευτικές και κοσμητικές συνθέσεις που περιλαμβάνουν τα εν λόγω συμπλέγματα.
CY20201100399T 2013-04-05 2020-04-30 Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο CY1122935T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13162453 2013-04-05
PCT/EP2014/056451 WO2014161815A1 (en) 2013-04-05 2014-03-31 Glycogen-based water solubility enhancers

Publications (1)

Publication Number Publication Date
CY1122935T1 true CY1122935T1 (el) 2021-10-29

Family

ID=48049850

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100399T CY1122935T1 (el) 2013-04-05 2020-04-30 Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο

Country Status (27)

Country Link
US (1) US10662259B2 (el)
EP (1) EP2981557B1 (el)
JP (1) JP6312801B2 (el)
KR (1) KR102113707B1 (el)
CN (1) CN105143274B (el)
AR (1) AR095937A1 (el)
AU (1) AU2014247145B2 (el)
BR (1) BR112015024825A2 (el)
CA (1) CA2905273A1 (el)
CY (1) CY1122935T1 (el)
DK (1) DK2981557T3 (el)
EA (1) EA032500B1 (el)
ES (1) ES2786900T3 (el)
GE (1) GEP201706742B (el)
HK (1) HK1215955A1 (el)
HR (1) HRP20200693T1 (el)
HU (1) HUE049561T2 (el)
IL (1) IL241690B (el)
LT (1) LT2981557T (el)
MX (1) MX369778B (el)
PL (1) PL2981557T3 (el)
PT (1) PT2981557T (el)
RS (1) RS60506B1 (el)
SG (2) SG10201708099YA (el)
SI (1) SI2981557T1 (el)
UA (1) UA119441C2 (el)
WO (1) WO2014161815A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105555856B (zh) 2013-04-26 2019-06-25 奇迹连结生物技术公司 植物糖原纳米颗粒及其制造方法
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
US11508407B2 (en) * 2018-03-30 2022-11-22 Sony Corporation Magnetic recording medium having controlled dimensional characteristics

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514720A (en) * 1974-10-07 1978-06-21 Secr Defence Preparation of hydroxyethyl starch
US4228277A (en) * 1979-02-12 1980-10-14 Hercules Incorporated Modified nonionic cellulose ethers
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5607839A (en) * 1993-07-22 1997-03-04 Nippon Oil Company, Ltd. Bacteria belonging to new genus process for production of carotenoids using same
US6248361B1 (en) * 1999-02-26 2001-06-19 Integ, Ltd. Water-soluble folic acid compositions
RU2303984C2 (ru) * 2001-08-22 2007-08-10 Супрамол Парентерал Коллоидс Гмбх Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя
DE10237442B4 (de) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Hochverzweigte, niedrig substituierte Stärkeprodukte
US7446101B1 (en) 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
WO2006040335A1 (en) * 2004-10-15 2006-04-20 Danisco A/S A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof
US7781572B2 (en) 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US9315715B2 (en) * 2009-10-20 2016-04-19 Nalco Company Method of reducing the viscosity of hydrocarbons
US8901092B2 (en) * 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
JP6247234B2 (ja) 2012-03-15 2017-12-13 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ グリコーゲンベースのカチオン性ポリマー
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine

Also Published As

Publication number Publication date
AR095937A1 (es) 2015-11-25
AU2014247145A1 (en) 2015-10-08
EA201591860A1 (ru) 2016-02-29
KR102113707B1 (ko) 2020-06-03
HK1215955A1 (zh) 2016-09-30
CN105143274A (zh) 2015-12-09
MX369778B (es) 2019-11-21
JP2016516857A (ja) 2016-06-09
AU2014247145B2 (en) 2018-03-22
BR112015024825A2 (pt) 2017-07-18
SI2981557T1 (sl) 2020-08-31
DK2981557T3 (da) 2020-04-27
MX2015013739A (es) 2016-06-21
CA2905273A1 (en) 2014-10-09
PT2981557T (pt) 2020-05-04
RS60506B1 (sr) 2020-08-31
PL2981557T3 (pl) 2020-10-19
ES2786900T3 (es) 2020-10-14
US20160068615A1 (en) 2016-03-10
SG11201507932RA (en) 2015-10-29
WO2014161815A1 (en) 2014-10-09
UA119441C2 (uk) 2019-06-25
SG10201708099YA (en) 2017-11-29
EP2981557A1 (en) 2016-02-10
HRP20200693T1 (hr) 2020-07-24
IL241690B (en) 2019-05-30
HUE049561T2 (hu) 2020-10-28
GEP201706742B (en) 2017-09-25
CN105143274B (zh) 2020-05-05
EP2981557B1 (en) 2020-02-05
EA032500B1 (ru) 2019-06-28
KR20150139877A (ko) 2015-12-14
LT2981557T (lt) 2020-07-27
US10662259B2 (en) 2020-05-26
JP6312801B2 (ja) 2018-04-18

Similar Documents

Publication Publication Date Title
CY1122966T1 (el) 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου
CY1124928T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
CY1120730T1 (el) Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1124007T1 (el) Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης
CY1120969T1 (el) Παραγωγα κινοξαλινης χρησιμα ως τροποποιητες fgfr κινασης
CY1121517T1 (el) Μη φουκοζυλιωμενα αντισωματα enanti-fgfr2iiib
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
CY1122786T1 (el) Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης
CY1119058T1 (el) Ενωσεις ιμιδαζοπυρρολιδινονης
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
CY1122796T1 (el) Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων
CY1121736T1 (el) Άλατα aramchol
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201600204A1 (ru) Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли
GT201400297A (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen
CY1124425T1 (el) Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
CY1120758T1 (el) Σταθερα στοματικα διαλυματα για συνδυασμενα εφς
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
CY1121881T1 (el) Φαρμακοτεχνικη μορφη που περιεχει σταθερη αναλογια ινσουλινης glargine/λιξισενατιδης
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
CY1124529T1 (el) Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινου
CY1122935T1 (el) Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο